Table S1 from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma

Autor:	Philippe Moreau, Jesús F. San-Miguel, Anil Singhal, Bruno Paiva, Anita Reddy, James P. Sheridan, Scott Gulbranson, Shekman Wong, Katja Weisel, Xavier Leleu, Andrzej J. Jakubowiak, Joaquín Martínez-López, Andreas Guenther, Marc S. Raab, Jesús G. Berdeja, María-Victoria Mateos, Daniel E.H. Afar, Rajneesh Nath, Ravi Vij
Rok vydání:	2023
Popis:	Overall summary of treatment-emergent adverse events
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072e401dc2fdc93db09c050b8ac6354a https://doi.org/10.1158/1078-0432.22471553.v1 Zobrazit plný text záznamu